Simulations of SELEX against complex receptors with a condensed statistical model

Computers and Chemical Engineering

Volumn 31, Issue 9, 2007, Pages 1007-1019

  Chen, Chi Kan ^a,b   Kuo, Tai Chih ^c,d  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

Author keywords

Aptamers; Computer model; Computer simulation; SELEX

Indexed keywords

COMPUTER SIMULATION; MATHEMATICAL MODELS; MEDICAL APPLICATIONS; NUMERICAL METHODS; PROTEINS; STATISTICAL METHODS;

APTAMERS; COMPUTER MODEL; RECEPTOR-SPECIFICITY; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT (SELEX);

NUCLEIC ACIDS;

COMPUTER SIMULATION; MATHEMATICAL MODELS; MEDICAL APPLICATIONS; NUCLEIC ACIDS; NUMERICAL METHODS; PROTEINS; STATISTICAL METHODS;

EID: 34248650687     PISSN: 00981354     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compchemeng.2006.08.015     Document Type: Article

References (41)

1. Adleman L.M. Molecular computation of solutions to combinatorial problems. Science 266 (1994) 1021-1024
2. Amstutz P., Forrer P., Zahnd C., and Pluckthun A. In vitro display technologies: Novel developments and applications. Current Opinion in Biotechnology 12 (2001) 400-405
3. Banzhaf W., Nordin P., Keller R.E., and Francone F.D. Genetic programming: An introduction on the automatic evolution of computer programs and its applications (1997), Morgan Kaufmann, New York
4. Becker K.C., and Becker R.C. Nucleic acid aptamers as adjuncts to vaccine development. Current Opinion in Molecular Therapy 8 (2006) 122-129
5. Blank M., and Blind M. Aptamers as tools for target validation. Current Opinion in Chemical Biology 9 (2005) 336-342
6. Breaker R.R. In vitro selection of catalytic polynucleotides. Chemical Reviews 97 (1997) 371-390
7. Breaker R.R. Engineered allosteric ribozymes as biosensor components. Current Opinion in Biotechnology 13 (2002) 31-39
8. Burgstaller P., Jenne A., and Blind M. Aptamers and aptazymes: Accelerating small molecule drug discovery. Current Opinion in Drug Discovery and Development 5 (2002) 690-700
9. Casella G., and Berger R.L. Statistical inference (2001), Thomson Learning/Duxbury Press, Pacific Grove, CA
10. Clark S.L., and Remcho V.T. Aptamers as analytical reagents. Electrophoresis 23 (2002) 1335-1340
11. Conrad R.C., Giver L., Tian Y., and Ellington A.D. In vitro selection of nucleic acid aptamers that bind proteins. Methods in Enzymology 267 (1996) 336-367
12. Daniels D.A., Chen H., Hicke B.J., Swiderek K.M., and Gold L. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 15416-15421
13. Doggrell S.A. Pegaptanib: The first antiangiogenic agent approved for neovascular macular degeneration. Expert Opinion in Pharmacotherapy 6 (2005) 1421-1423
14. Ellington A.D., and Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 346 (1990) 818-822
15. Famulok M., Blind M., and Mayer G. Intramers as promising new tools in functional proteomics. Chemistry and Biology 8 (2001) 931-939
16. Faulhammer D., Cukras A.R., Lipton R.J., and Landweber L.F. Molecular computation: RNA solutions to chess problems. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 1385-1389
17. Gibbons A., Amos M., and Hodgson D. DNA computing. Current Opinion in Biotechnology 8 (1997) 103-106
18. Griffiths A.D., and Tawfik D.S. Man-made enzymes from design to in vitro compartmentalisation. Current Opinion in Biotechnology 11 (2000) 338-353
19. Guerrier-Takada C., Gardiner K., Marsh T., Pace N., and Altman S. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35 (1983) 849-857
20. Hicke B.J., Marion C., Chang Y.F., Gould T., Lynott C.K., Parma D., Schmidt P.G., and Warren S. Tenascin-C aptamers are generated using tumor cells and purified protein. Journal of Biological Chemistry 276 (2001) 48644-48654
21. Irvine D., Tuerk C., and Gold L. SELEXION. Systematic evolution of ligands by exponential enrichment with integrated optimization by non-linear analysis. Journal of Molecular Biology 222 (1991) 739-761
22. James W. Nucleic acid and polypeptide aptamers: A powerful approach to ligand discovery. Current Opinion in Pharmacology 1 (2001) 540-546
23. Jaschke A. Artificial ribozymes and deoxyribozymes. Current Opinion in Structural Biology 11 (2001) 321-326
24. Jaschke A., and Seelig B. Evolution of DNA and RNA as catalysts for chemical reactions. Current Opinion in Chemical Biology 4 (2000) 257-262
25. Joyce G.F. Directed evolution of nucleic acid enzymes. Annual Review of Biochemistry 73 (2004) 791-836
26. Koza J.R., Keane M.A., Streeter M.J., Mydlowec W., Yu J., and Lanza G. Genetic programming IV: Routine human-competitive machine intelligence (2005), Morgan Kaufmann, New York
27. Lancet D., Sadovsky E., and Seidemann E. Probability model for molecular recognition in biological receptor repertoires: Significance to the olfactory system. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 3715-3719
28. Mandal M., and Breaker R.R. Gene regulation by riboswitches. Nature Review in Molecular and Cell Biology 5 (2004) 451-463
29. Mayer G., and Jenne A. Aptamers in research and drug development. BioDrugs 18 (2004) 351-359
30. Morris K.N., Jensen K.B., Julin C.M., Weil M., and Gold L. High affinity ligands from in vitro selection: Complex targets. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 2902-2907
31. Parker J. Computing with DNA. EMBO Report 4 (2003) 7-10
32. Rosenwald S., Kafri R., and Lancet D. Test of a statistical model for molecular recognition in biological repertoires. Journal of Theoretical Biology 216 (2002) 327-336
33. Sen D. Aptamer rivalry. Chemistry and Biology 9 (2002) 851-852
34. Smith G.P. Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science 228 (1985) 1315-1317
35. Szostak J.W. Introduction: Combinatorial chemistry. Chemical Reviews 97 (1997) 347-348
36. Tabor J.J., and Ellington A.D. Playing to win at DNA computation. Nature Biotechnology 21 (2003) 1013-1015
37. Tuerk C., and Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249 (1990) 505-510
38. Vant-Hull B., Payano-Baez A., Davis R.H., and Gold L. The mathematics of SELEX against complex targets. Journal of Molecular Biology 278 (1998) 579-597
39. Wilson D.S., and Szostak J.W. In vitro selection of functional nucleic acids. Annual Review of Biochemistry 68 (1999) 611-647
40. Yang C.N., and Yang C.B. A DNA solution of SAT problem by a modified sticker model. Biosystems 81 (2005) 1-9
41. Zaug A.J., and Cech T.R. In vitro splicing of the ribosomal RNA precursor in nuclei of Tetrahymena. Cell 19 (1980) 331-338